Clinical Trials
177 trialsMultimodal Machine Learning Characterization of Solid Tumors
Massachusetts General Hospital
Study of Kidney Tumors in Younger Patients
Children's Oncology Group
ZEBRA
Istituto Oncologico Veneto IRCCS
TraveraRTGx
Travera Inc
VolUS3D
Assistance Publique - Hôpitaux de Paris
NOTION: iN-home Sampling Of cyTokines in ImmunOtherapy patieNts
The Christie NHS Foundation Trust
KIDCaD
Charles University, Czech Republic
ADONIS
Pfizer
A Study to Learn About the First and Later Lines of Medicines in Treating People With Metastatic Renal Cell Carcinoma (mRCC).
Pfizer
RREIN
University Hospital, Lille
Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes
City of Hope Medical Center
Feasibility of a Smart-Phone App for Patients With Advanced Renal Cell Carcinoma Undergoing Combination Immunotherapy
H. Lee Moffitt Cancer Center and Research Institute
An Observational Study to Evaluate the Efficacy and Safety of Avelumab + Axitinib Combination in Participants With aRCC (AVION)
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
CT-based Radiomics for Prediction of MIT Family Translocation Kidney Cancer: a Multicenter, Retrospective Clinical Study
First Affiliated Hospital of Fujian Medical University
Computed Tomography Radiomics-Derived Nomogram for Predicting Early Renal Function Decline After Partial Nephrectomy in Renal Cell Carcinoma: A Multicenter Development/Validation Study
First Affiliated Hospital of Fujian Medical University
Post-Marketing Surveillance Study To Observe INLYTA® Treatment Dosing Pattern, Safety And Effectiveness In Taiwan Real World Routine Practice
Pfizer
Real-Life Effectiveness and Safety in Participants With Advanced/Metastatic Renal Cell Carcinoma Starting 1st Line Nivolumab and Ipilimumab Combination Therapy or Nivolumab Monotherapy After Prior Therapy
Bristol-Myers Squibb
AUR87A
Elypta
Measuring Treatment Response in Metastatic Renal Cell Cancer Using FPIA PET/CT
Imperial College London
Clinical Study of 18F -FAPI-RGD in Renal Tumor
Sichuan Provincial People's Hospital
Survey of Cabozantinib Used To Treat People With Renal Cell Carcinoma
Takeda
J-DART2
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Tertiary Lymphoid Structures Related Genes Predicting Prognosis in Clear Cell Renal Cell Carcinoma: a Retrospective Cohort Study
Fudan University
The CT-based Deep Learning Model Predicts Complications in Partial Nephrectomy
Fudan University
REVOLUTION
National Cancer Institute, Naples
CRYO-BO-2021
IRCCS Azienda Ospedaliero-Universitaria di Bologna
A Study of Nivolumab Plus Ipilimumab in Participants With Renal Cell Cancer in the Real World Setting in Japan
Bristol-Myers Squibb
HPGD-ccRCC
Lanzhou University Second Hospital
Development of AI Model for Renal Tumor Diagnosis Using CT and Lab Tests
RenJi Hospital
To Examine the Effects of Axitinib Dose Reduction and Interruption for Adverse Event Management Among Patients Receiving Axitinib in for the Treatment of Advanced Renal Cell Carcinoma
Pfizer
ROOT
Taproot Health
A Multimodal Predictive Recurrence Score for Patients With Clear Cell Renal Cell Carcinoma
RenJi Hospital
Disease Burden and Biology Using Tumor Cell Free DNA in Metastatic Kidney Cancer
Vanderbilt-Ingram Cancer Center
REMEDY
University Health Network, Toronto
IMNR
Dr. Lutfi Kirdar Kartal Training and Research Hospital
A Study to Describe the Kidney Cancer Patient Population Treatment, and Results in the Hospital District of Southwest Finland.
Pfizer
Temsirolimus (Torisel) Drug Use Investigation (Regulatory Post Marketing Commitment Plan)
Pfizer
Master Protocol to Study Treatment Patterns, Medication Adherence, Health and Economic Outcomes and Unmet Needs in RCC
Pfizer
A CT-BASED Deep Learning Model for Predicting WHO/ISUP Pathological Grades of Clear Cell Renal Cell Carcinoma (ccRCC) :A Multicenter Cohort Study
Zhejiang University
Immunophenotyping in Metastatic Kidney Cancer Patients Receiving Ablative Therapy
Mayo Clinic
A Study to go Back Into Records and Observe How People With Metastatic Renal Cell Carcinoma (mRCC) Who Received a Medicine Called Sunitinib Responded to This Medicine.
Pfizer
Collection of Blood, Bone Marrow, Tumor, or Tissue Samples From Patients With Cancer to Study Drug Resistance
National Institutes of Health Clinical Center (CC)
Novel Prognostic Markers in Renal Cancer
Royal Marsden NHS Foundation Trust
Post-marketing Surveillance on the Safety of CabometyxTM in Korean Patients
Ipsen
Renimage
University Medical Center Groningen
VHLimage
University Medical Center Groningen
Everolimage
University Medical Center Groningen
BANN
University Medical Center Groningen
A Study of Lenvatinib in Combination With Pembrolizumab in Korean Patients
Eisai Inc.
LiangAH
The First Affiliated Hospital of Anhui Medical University